MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
PHG stock logo

PHG

Koninklijke Philips N.V.

$25.88
-0.62
 (-2.34%)
Exchange:  NYSE
Market Cap:  25.136B
Shares Outstanding:  1.143B
Delayed data
Calculate PHG Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Devices
   
CEO:  Roy W. O. Jakobs
Full Time Employees:  67247
Address: 
Philips Center
Amsterdam
1096 BC
NL
Website:  https://www.philips.com
Koninklijke Philips N.V. (PHG) functions as a prominent health technology enterprise, with its operations spanning across North America and numerous international markets. The company’s diverse activities are organized into three primary business divisions: Diagnosis & Treatment, Connected Care, and Personal Health. Within its Diagnosis & Treatment segment, Philips delivers advanced diagnostic imaging solutions, which include magnetic resonance imaging (MRI), computed tomography (CT) systems, X-ray apparatus, and spectral CT technology based on detector platforms. This division also provides molecular and hybrid imaging capabilities crucial for nuclear medicine. Furthermore, it offers integrated systems for interventional procedures, along with ultrasound (echography) solutions specifically designed for diagnosis, treatment planning, and guidance in fields such as cardiology, general imaging, obstetrics/gynecology, and point-of-care applications. Complementing these are proprietary software tools for diagnostic and interventional support, alongside comprehensive enterprise diagnostic informatics products and associated services. The Connected Care division focuses on providing solutions for acute patient management, emergency care services, and specialized offerings for sleep and respiratory conditions. This also encompasses electronic medical record (EMR) systems and broader care management platforms. Meanwhile, the Personal Health segment caters to consumer well-being with products such as electric toothbrushes, replacement brush heads, interdental cleaning aids, and teeth whitening kits. It also manufactures infant feeding products and digital parental support tools, in addition to a range of male grooming and beauty products. Philips has forged significant strategic alliances, notably a collaboration with Ibex Medical Analytics Ltd. This partnership aims to jointly promote digital pathology and AI-driven solutions to hospitals, healthcare networks, and pathology laboratories worldwide. The company also maintains a key partnership agreement with NICO.LAB. Established in 1891, the company was initially known as Koninklijke Philips Electronics N.V. before officially rebranding as Koninklijke Philips N.V. in May 2013. Its corporate headquarters are located in Amsterdam, the Netherlands.

Click to read more…

Revenue Segmentation

MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/06 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue18,169,00018,021,00017,834,000
Gross Profit7,448,0007,773,0008,058,000
EBITDA1,041,0001,849,0002,639,344.311
Operating Income-115,000529,0001,424,000
Net Income-466,000-702,000895,000

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets29,406,00028,976,00026,944,000
Total Liabilities17,345,00016,933,00015,955,000
Total Stockholders Equity12,028,00012,006,00010,957,000
Total Debt7,293,0007,491,0008,085,000
Cash and Cash Equivalents1,869,0002,401,0002,794,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow2,136,0001,556,0001,162,000
Capital Expenditure-644,000-676,000-269,000
Free Cash Flow1,492,000893,000893,000
Net Income-466,000-702,000895,000
Net Change in Cash697,000532,000393,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)20,789,219.615Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)22,683,176.401Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)21,454,129.128Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)4,558,529.761Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)4,973,824.732Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)4,704,326.951Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)2,054,674.406Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)2,300,372.547Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)2,140,933.925Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)5,913,821.157Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)6,452,587.013Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)6,102,965.147Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)2.220Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)2.390Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)2.130Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)5Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
19.493B  ?P/S
 (TTM)
: 
1.25
?Net Income
 (TTM)
: 
-910783616.8  ?P/E
 (TTM)
: 
22.3
?Enterprise Value
 (TTM)
: 
27.598B  ?EV/FCF
 (TTM)
: 
14.45
?Dividend Yield
 (TTM)
: 
0.04  ?Payout Ratio
 (TTM)
: 
0.34
?ROE
 (TTM)
: 
0.09  ?ROIC
 (TTM)
: 
0.06
?Net Debt
 (TTM)
: 
5.424B  ?Debt/Equity
 (TTM)
: 
0.71
?P/B
 (TTM)
: 
1.9  ?Current Ratio
 (TTM)
: 
1.32

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
14.35Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about PHG valuation

Is Koninklijke Philips N.V. (PHG) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Koninklijke Philips N.V. (PHG) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is PHG a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether PHG trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is PHG’s P/E ratio?

You can see PHG’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for PHG?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is PHG a good long-term investment?

Whether PHG fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

PHG

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-2.34
MARKETSnap

Trading Metrics:

Open: 26.11   Previous Close: 26.5
Day Low: 25.86   Day High: 26.12
Year Low: 21.95   Year High: 33.44
Price Avg 50: 27.02   Price Avg 200: 28.04
Volume: 204468   Average Volume: 1.151M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

AI is boosting accuracy for clinicians, Philips North America CEO says
09-06-2026 13:07
AI is boosting accuracy for clinicians, Philips North America CEO says
AI Moves from Promise to Practice, Transforming Clinical Care Across the U.S., Philips Report Finds
09-06-2026 04:00
AI Moves from Promise to Practice, Transforming Clinical Care Across the U.S., Philips Report Finds
AI Moves from Promise to Practice, Transforming Clinical Care Across the U.S., Philips Report Finds
09-06-2026 04:00
Philips Future Health Index 2026: AI is already saving clinicians time and delivering measurable impact in healthcare
WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland
04-06-2026 04:00
WellSpan Health and Philips Announce Landmark Strategic Alliance, Accelerating Innovation and Research Across Central Pennsylvania and Northern Maryland
Philips announces exchange ratio for 2025 dividend
02-06-2026 04:00
Philips announces exchange ratio for 2025 dividend
Koninklijke Philips: AI Upside, And Margin Expansion Create An Attractive Entry Point
20-05-2026 06:38
Koninklijke Philips: AI Upside, And Margin Expansion Create An Attractive Entry Point

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read